Flagship Harbor Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Flagship Harbor Advisors's CRL Position: Q1 2026 in Review
Flagship Harbor Advisors sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 70 shares — an estimated $14K sold.
Flagship Harbor Advisors first reported a position in CRL in Q2 2018 and held it in 19 quarters. The position peaked at $445K in Q1 2024. 559 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Flagship Harbor Advisors reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
- Flagship Harbor Advisors sold 70 Charles River Laboratories shares in Q1 2026, an estimated $14K.
- Flagship Harbor Advisors first reported a position in Charles River Laboratories in Q2 2018 and held it in 19 quarters.
- Flagship Harbor Advisors's Charles River Laboratories position peaked at $445K in Q1 2024.
- 559 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.